MOREPEN LABORATORIES
MOREPENLABVerifiedMOREPEN LABORATORIES is a publicly traded security listed on the NSE/BSE exchange.
Stock Snapshot & Key Numbers — MOREPEN LABORATORIES
Verified Daily CloseOfficial closing price, 1-year price range, valuation multiples, and market value from exchange records.
MOREPEN LABORATORIES (MOREPENLAB) is a Indian equity security listed on the NSE/BSE with ISIN BSE:500288. As of the last recorded market session on Close on 16 Oct 2026, the stock closed at ₹123.87, recording a -1.73 (-1.38%) decline from its previous close of ₹125.60. Over the trailing 52-week trading cycle, MOREPENLAB has traded between a 52-week low of ₹33.68 and a 52-week high of ₹146.97, establishing its annual trading channel. In historical performance, MOREPEN LABORATORIES has gained 155.45% over the past 1 year. Period returns across standard measurement intervals include: 1-week: -4.38%, 1-month: +7.97%, 6-month: +200.87%, 1-year: +155.45%, 3-year: +249.92%, 5-year: +130.67%. Daily reported trading volume reached 26,65,655 equity shares. On key valuation multiples as of 11 Oct 2026, the company trades at a trailing price-to-earnings (P/E) multiple of 50.6x and a price-to-book (P/B) ratio of 5.8x, with a trailing dividend yield of 0.15%. Its market capitalization stands at ₹7,098.74 Cr. The company is categorized under the Diversified Indian Equities sector and Public Market Listed Security industry within the Indian equities universe.
Price Chart
Trading Multiples & Ranges
Price boundaries and liquidity distribution.
Past Price Win/Loss Odds (1-Week, 1-Month, 3-Month)
How often this stock rose, stayed flat, or fell over past 21-day holding periods (based on historical data, not a future prediction).
How Outside Factors Affect This Stock (Market, Crude Oil & Currency)
How closely this stock moved with the broader market index, crude oil, and the exchange rate over the past year.
| Factor / Benchmark | 1Y Beta (Sensitivity) | 1Y Correlation (-1 to +1) | What This Means |
|---|---|---|---|
| NIFTY 50 | +1.45 | +0.35 | Trailing 1Y historical sensitivity: a 1% move in NIFTY 50 coincided with a +1.45% co-movement (correlation: 0.35). Descriptive historical relationship, not predictive. |
| USD / INR | -1.44 | -0.19 | Trailing 1Y historical sensitivity: a 1% move in USD / INR coincided with a -1.44% co-movement (correlation: -0.19). Descriptive historical relationship, not predictive. |
| Brent Crude Oil | -0.25 | -0.24 | Trailing 1Y historical sensitivity: a 1% move in Brent Crude Oil coincided with a -0.25% co-movement (correlation: -0.24). Descriptive historical relationship, not predictive. |
| US 10Y Treasury Yield | -0.27 | -0.07 | Trailing 1Y historical sensitivity: a 1% move in US 10Y Treasury Yield coincided with a -0.27% co-movement (correlation: -0.07). Descriptive historical relationship, not predictive. |
How to read Beta & Correlation ( Beta > 1 = wider swings than market; < 1 = calmer )▾
Sensitivities measure historical 1-year regression beta and correlation across paired daily trading sessions over the past 252 trading days. Past relationships can shift over time and do not guarantee future co-movement.
Trailing Returns Breakdown
Calendar-aligned historical percentage performance across standard market windows.
| Period | Start Price | Current Price | Return (%) |
|---|---|---|---|
| 1 Week | ₹129.55 | ₹123.87 | -4.38% |
| 15 Days | ₹133.72 | ₹123.87 | -7.37% |
| 1 Month | ₹114.73 | ₹123.87 | +7.97% |
| 3 Months | ₹60.83 | ₹123.87 | +103.63% |
| 6 Months | ₹41.17 | ₹123.87 | +200.87% |
| 1 Year | ₹48.49 | ₹123.87 | +155.45% |
| 3 Years | ₹35.40 | ₹123.87 | +249.92% |
| 5 Years | ₹53.70 | ₹123.87 | +130.67% |
Price Swings & Biggest Historical Drops
How much this stock typically fluctuates and its largest peak-to-bottom drops over 1 and 5 years.
Calendar-Year Historical Performance
Annual performance breakdown comparing first and last closing sessions of each calendar year.
| Calendar Year | Start Close | End Close | Annual Return | Trajectory Bar |
|---|---|---|---|---|
| CY 2026 | ₹41.11 | ₹123.87 | +201.3% | |
| CY 2025 | ₹79.19 | ₹41.07 | -48.1% | |
| CY 2024 | ₹49.10 | ₹78.16 | +59.2% | |
| CY 2023 | ₹36.05 | ₹48.55 | +34.7% | |
| CY 2022 | ₹57.35 | ₹37.85 | -34.0% | |
| CY 2021 | ₹53.70 | ₹56.25 | +4.8% |
Historical Investment Simulator
Factual simulation of past returns in MOREPEN LABORATORIES (MOREPENLAB) using real recorded closing prices.
Corporate Actions & Distributions
Historical record of dividend payouts and share split adjustments for MOREPENLAB.
Dividend Distributions (1)
| Ex-Date | Dividend Amount |
|---|---|
| 18 Sep 2026 | ₹0.20 per share |
Stock Splits & Multipliers (0)
No stock split adjustments recorded.
Recent News & Official Exchange Announcements
Official exchange filings, order wins, and company updates. Click any announcement to see how it affects the business on the right.
We Ran A Stock Scan For Earnings Growth And Morepen Laboratories (NSE:MOREPENLAB) Passed With Ease - Simply Wall Street
We Ran A Stock Scan For Earnings Growth And Morepen Laboratories (NSE:MOREPENLAB) Passed With Ease Simply Wall Street
Morepen Laboratories (NSE:MOREPENLAB): Has It Completed Phase One of Capacity Expansion? - Kalkine India
Morepen Laboratories (NSE:MOREPENLAB): Has It Completed Phase One of Capacity Expansion? Kalkine India
Morepen Laboratories Ltd. Share Price, Stock Price - NSE/BSE Live - NDTV Profit
Morepen Laboratories Ltd. Share Price, Stock Price - NSE/BSE Live NDTV Profit
Morepen Laboratories Q1 results FY27: PAT Rs 56 Cr, Revenue Rs 57 - Univest
Morepen Laboratories Q1 results FY27: PAT Rs 56 Cr, Revenue Rs 57 Univest
Morepen Laboratories' (NSE:MOREPENLAB) Shareholders Have More To Worry About Than Only Soft Earnings - Simply Wall Street
Morepen Laboratories' (NSE:MOREPENLAB) Shareholders Have More To Worry About Than Only Soft Earnings Simply Wall Street
Why This Matters for the Business
Plain-English breakdown of how the selected announcement connects to revenue, costs, and business drivers.
Financial performance outpaced historical baseline, driving operating leverage and valuation re-rating.
- •Financial performance and operating margins expanded ahead of consensus projections
Volume throughput absorbs fixed manufacturing plant overheads, supporting operating EBITDA margins and cash generation across diversified indian equities units.
Continuous commercial tenders and capital expenditures lock in forward order book-to-bill expansion.
At-a-Glance Health & Momentum Check
Recent exchange filings and reported financial statements show healthy alignment between revenue growth, operating cash flow, and improving profit margins.
Peer & Sector Comparison — Next Research Steps
Exit points and comparative equity universe: same-sector peers, shared macro sensitivity betas, and your watchlist.
Common Questions About MOREPEN LABORATORIES (MOREPENLAB)
Key facts on MOREPENLAB share price, historical returns, valuation ratios, and past SIP performance.
What is the current share price and 52-week range of MOREPEN LABORATORIES (MOREPENLAB)?
As of 16 Oct 2026, the official closing share price of MOREPEN LABORATORIES (MOREPENLAB) on NSE/BSE is ₹123.87 (-1.38% vs the previous close). Over the past 52 weeks, MOREPENLAB has traded between a low of ₹33.68 and a high of ₹146.97, with a reported market capitalization of ₹7,098.74 Cr.
What are the historical returns of MOREPEN LABORATORIES (MOREPENLAB)?
Based on split-adjusted closing prices through 16 Oct 2026, MOREPEN LABORATORIES (MOREPENLAB) recorded the following trailing price returns: 1 Week: -4.38% (from ₹129.55 to ₹123.87); 15 Days: -7.37% (from ₹133.72 to ₹123.87); 1 Month: +7.97% (from ₹114.73 to ₹123.87); 3 Months: +103.63% (from ₹60.83 to ₹123.87); 6 Months: +200.87% (from ₹41.17 to ₹123.87); 1 Year: +155.45% (from ₹48.49 to ₹123.87); 3 Years: +249.92% (from ₹35.40 to ₹123.87); 5 Years: +130.67% (from ₹53.70 to ₹123.87). Past performance reflects historical exchange records and does not predict future returns.
What is the P/E ratio, P/B ratio, and dividend yield of MOREPEN LABORATORIES (MOREPENLAB)?
MOREPEN LABORATORIES (MOREPENLAB) currently trades at a trailing Price-to-Earnings (P/E) ratio of 50.6x, a Price-to-Book (P/B) ratio of 5.8x, and a trailing 12-month dividend yield of 0.15%. It operates in the Diversified Indian Equities sector (Public Market Listed Security).
How much would a past lump-sum or monthly SIP investment in MOREPENLAB have grown?
Based on historical closing prices for MOREPEN LABORATORIES (MOREPENLAB): A one-time lump-sum investment of ₹1,00,000.00 held for 5 years would be worth ₹2,30,670.39 (+130.7% total return, 18.2% CAGR), while a monthly SIP of ₹10,000.00 over 5 years (total invested: ₹6,10,000.00) would be worth ₹17,21,259.43 (+182.2% absolute return). You can test custom amounts and holding periods in the interactive calculator above.
Official Corporate Perspective
Authorized Investor Relations officers may submit authenticated context or coordinate with our research team.